Cargando…
Abstract 116: Clinical and biochemical predictors in early pregnancy for development of gestational diabetes mellitus
Background: Early prediction of GDM is vital. Current risk prediction models are based on maternal and clinical parameters, lacking a strong predictive value. Objective: To identify clinical and biochemical parameters in early pregnancy for prediction of GDM. Methods: In this prospective cohort stud...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067727/ http://dx.doi.org/10.4103/2230-8210.342241 |
_version_ | 1784700069517197312 |
---|---|
author | Manglunia, Ankit Kanwar, JayaBhanu Mangaraj, Swayamsidha Swain, Jayshree Sahoo, Abhay Sahu, Manisha Pati, Tapasi Mishra, Sujata Pattnaik, Tapan Das, Sasmita Panigrahy, Rajashree Gochhait, Somanyoya |
author_facet | Manglunia, Ankit Kanwar, JayaBhanu Mangaraj, Swayamsidha Swain, Jayshree Sahoo, Abhay Sahu, Manisha Pati, Tapasi Mishra, Sujata Pattnaik, Tapan Das, Sasmita Panigrahy, Rajashree Gochhait, Somanyoya |
author_sort | Manglunia, Ankit |
collection | PubMed |
description | Background: Early prediction of GDM is vital. Current risk prediction models are based on maternal and clinical parameters, lacking a strong predictive value. Objective: To identify clinical and biochemical parameters in early pregnancy for prediction of GDM. Methods: In this prospective cohort study, we screened 581 consecutive healthy women with singleton pregnancy for GDM during their first antenatal visit. Fasting blood samples were collected and stored at -80(0)C. Detailed history and clinical assessment were done for each patient and findings were noted in a pre-specified proforma. GDM was diagnosed as per IADPSG criteria at 24-28 weeks. During prospective follow up, 55 patients developed GDM. A total of 110 age and BMI matched controls were recruited for comparison. We measured OGTT, fasting insulin, HbA1c, hsCRP, uric acid and Lipid Profile. HOMA-IR, HOMA-β and QUICKI were used to estimate insulin sensitivity and β-cell function. Results: Significant higher proportion of subjects in GDM cohort had presence of Acanthosis nigricans, positive family history of T2DM in 1(st) degree relative. GDM cohort had significantly higher waist circumference, 2 hr plasma glucose, HbA1c, fasting insulin, HOMA-IR, uric acid and serum triglyceride levels. The area under the curve were as follows: HbA1c - 0.71 (95%CI: 0.628–0.793), Fasting Insulin - 0.748 (95%CI: 0.671–0.826), hsCRP - 0.634 (95%CI: 0.546 - 0.722) and Uric acid - 0.693 (95%CI: 0.606–0.780). Multiple regression analysis revealed HbA1c (OR 4.225; 95%CI – 1.421-12.561), 2 hr PPG (OR 1.026; 95%CI – 1.003-1.049), Insulin (OR 1.057; 95%CI – 1.006-1.111) and uric acid (OR 1.039; 95%CI – 1.026-2.793) to be independently associated with GDM outcome. Conclusions: Fasting Insulin, HbA1c, HOMA-IR, hsCRP and Uric acid levels are significantly altered in early pregnancy in individuals who develop GDM subsequently. Hence utilization of these parameters may identify at risk group in routine clinical care and help in improving feto-maternal outcome. |
format | Online Article Text |
id | pubmed-9067727 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-90677272022-05-05 Abstract 116: Clinical and biochemical predictors in early pregnancy for development of gestational diabetes mellitus Manglunia, Ankit Kanwar, JayaBhanu Mangaraj, Swayamsidha Swain, Jayshree Sahoo, Abhay Sahu, Manisha Pati, Tapasi Mishra, Sujata Pattnaik, Tapan Das, Sasmita Panigrahy, Rajashree Gochhait, Somanyoya Indian J Endocrinol Metab Abstracts … Esicon 2021 Background: Early prediction of GDM is vital. Current risk prediction models are based on maternal and clinical parameters, lacking a strong predictive value. Objective: To identify clinical and biochemical parameters in early pregnancy for prediction of GDM. Methods: In this prospective cohort study, we screened 581 consecutive healthy women with singleton pregnancy for GDM during their first antenatal visit. Fasting blood samples were collected and stored at -80(0)C. Detailed history and clinical assessment were done for each patient and findings were noted in a pre-specified proforma. GDM was diagnosed as per IADPSG criteria at 24-28 weeks. During prospective follow up, 55 patients developed GDM. A total of 110 age and BMI matched controls were recruited for comparison. We measured OGTT, fasting insulin, HbA1c, hsCRP, uric acid and Lipid Profile. HOMA-IR, HOMA-β and QUICKI were used to estimate insulin sensitivity and β-cell function. Results: Significant higher proportion of subjects in GDM cohort had presence of Acanthosis nigricans, positive family history of T2DM in 1(st) degree relative. GDM cohort had significantly higher waist circumference, 2 hr plasma glucose, HbA1c, fasting insulin, HOMA-IR, uric acid and serum triglyceride levels. The area under the curve were as follows: HbA1c - 0.71 (95%CI: 0.628–0.793), Fasting Insulin - 0.748 (95%CI: 0.671–0.826), hsCRP - 0.634 (95%CI: 0.546 - 0.722) and Uric acid - 0.693 (95%CI: 0.606–0.780). Multiple regression analysis revealed HbA1c (OR 4.225; 95%CI – 1.421-12.561), 2 hr PPG (OR 1.026; 95%CI – 1.003-1.049), Insulin (OR 1.057; 95%CI – 1.006-1.111) and uric acid (OR 1.039; 95%CI – 1.026-2.793) to be independently associated with GDM outcome. Conclusions: Fasting Insulin, HbA1c, HOMA-IR, hsCRP and Uric acid levels are significantly altered in early pregnancy in individuals who develop GDM subsequently. Hence utilization of these parameters may identify at risk group in routine clinical care and help in improving feto-maternal outcome. Wolters Kluwer - Medknow 2022-03 /pmc/articles/PMC9067727/ http://dx.doi.org/10.4103/2230-8210.342241 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Abstracts … Esicon 2021 Manglunia, Ankit Kanwar, JayaBhanu Mangaraj, Swayamsidha Swain, Jayshree Sahoo, Abhay Sahu, Manisha Pati, Tapasi Mishra, Sujata Pattnaik, Tapan Das, Sasmita Panigrahy, Rajashree Gochhait, Somanyoya Abstract 116: Clinical and biochemical predictors in early pregnancy for development of gestational diabetes mellitus |
title | Abstract 116: Clinical and biochemical predictors in early pregnancy for development of gestational diabetes mellitus |
title_full | Abstract 116: Clinical and biochemical predictors in early pregnancy for development of gestational diabetes mellitus |
title_fullStr | Abstract 116: Clinical and biochemical predictors in early pregnancy for development of gestational diabetes mellitus |
title_full_unstemmed | Abstract 116: Clinical and biochemical predictors in early pregnancy for development of gestational diabetes mellitus |
title_short | Abstract 116: Clinical and biochemical predictors in early pregnancy for development of gestational diabetes mellitus |
title_sort | abstract 116: clinical and biochemical predictors in early pregnancy for development of gestational diabetes mellitus |
topic | Abstracts … Esicon 2021 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067727/ http://dx.doi.org/10.4103/2230-8210.342241 |
work_keys_str_mv | AT mangluniaankit abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus AT kanwarjayabhanu abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus AT mangarajswayamsidha abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus AT swainjayshree abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus AT sahooabhay abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus AT sahumanisha abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus AT patitapasi abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus AT mishrasujata abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus AT pattnaiktapan abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus AT dassasmita abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus AT panigrahyrajashree abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus AT gochhaitsomanyoya abstract116clinicalandbiochemicalpredictorsinearlypregnancyfordevelopmentofgestationaldiabetesmellitus |